tiprankstipranks
Ribomic, Inc. (JP:4591)
:4591
Japanese Market
4591
Ribomic, Inc.
RESEARCH TOOLSreports
Want to see JP:4591 full AI Analyst Report?

Ribomic, Inc. (4591) Stock News & Sentiment

0 Followers
Ribomic Completes Site Network for Phase 3 Achondroplasia Trial in Japan
Premium
Company Announcements
Ribomic Completes Site Network for Phase 3 Achondroplasia Trial in Japan
21d ago
4591
Ribomic Posts Quarterly Loss but Maintains Strong Equity Base and Full-Year Outlook
Premium
Company Announcements
Ribomic Posts Quarterly Loss but Maintains Strong Equity Base and Full-Year Outlook
1M ago
4591
RIBOMIC Begins Phase 3 Trial of Orphan Drug Umedaptanib Pegol for Paediatric Achondroplasia
Premium
Company Announcements
RIBOMIC Begins Phase 3 Trial of Orphan Drug Umedaptanib Pegol for Paediatric Achondroplasia
2M ago
4591
Ribomic Widens Losses but Boosts Liquidity as It Projects Deeper Red Ink
Premium
Company Announcements
Ribomic Widens Losses but Boosts Liquidity as It Projects Deeper Red Ink
4M ago
4591
RIBOMIC Files IND for Phase III Trial of Achondroplasia Drug in Japan
Premium
Company Announcements
RIBOMIC Files IND for Phase III Trial of Achondroplasia Drug in Japan
6M ago
4591
Ribomic’s Achondroplasia Drug Hits Phase II Height-Growth Goal, Paving Way for Phase III
Premium
Company Announcements
Ribomic’s Achondroplasia Drug Hits Phase II Height-Growth Goal, Paving Way for Phase III
6M ago
4591
RIBOMIC Posts Continued Losses but Maintains Strong Equity Base in Nine-Month Results
Premium
Company Announcements
RIBOMIC Posts Continued Losses but Maintains Strong Equity Base in Nine-Month Results
7M ago
4591
More JP:4591 News >

4591 News on the Web

RIBOMIC Begins Phase 3 Trial of Orphan Drug Umedaptanib Pegol for Paediatric Achondroplasia
TipRanks News
Bullish
RIBOMIC Files IND for Phase III Trial of Achondroplasia Drug in Japan
TipRanks News
Bullish
Ribomic’s Achondroplasia Drug Hits Phase II Height-Growth Goal, Paving Way for Phase III
TipRanks News
Bullish
RIBOMIC Posts Continued Losses but Maintains Strong Equity Base in Nine-Month Results
TipRanks News
Bearish
Ribomic Files Patent for High-Activity Eye-Disease Aptamer RBM-006 After Positive Diabetic Retinopathy Data
TipRanks News
Bullish
RIBOMIC Reports Positive Phase 2 Trial Results for Achondroplasia Treatment
TipRanks News
Neutral
RIBOMIC Reports Positive Phase 2 Trial Results for Achondroplasia Treatment
TipRanks News
Neutral
RIBOMIC Discovers New Treatment Potential for Diabetic Retinopathy
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.5 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JP:4591’s Media Buzz Sentiment?
Currently, no data Available
What is JP:4591’s weekly average amount of articles?
In an average week, 0.5 articles about JP:4591 are published.
    What is JP:4591’s News Sentiment?
    Currently, no data Available
    General Stocks that are Trending in the News
    RPDRapid7
    TERATera Yatirim Menkul Degerler AS
    R2PD34Rapid7 Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh
    T2TD34Trade Desk, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.01 Sh A
    T1AM34Atlassian Corp Shs A Unsponsored Brazilian Depository Receipt Repr 0.05 Sh A
    Showing the stocks with the most bullish news sentiment over the past week